FreeTheAI

Medical Care Technologies Secures First Paid AI Software Contract Worth Up to $250,000

MixedLow impact
MDCE$0.0001 100.00%

Medical Care Technologies, Inc. (OTC:MDCE) has secured a multi-year software agreement valued at up to $250,000. The deal represents the company's first external commercial sale of its artificial intelligence platform, with initial payment processing already underway.

The contract marks a transition toward commercial revenue following a period of building AI platform technology with limited external sales. While specific application details were not revealed, the agreement includes ongoing financial incentives that could provide further upside to the contract value.

Looking ahead, investors will watch for detailed contract terms, repeat customer acquisitions, and evidence of scalable operating margins. On the day of the announcement, shares of Medical Care Technologies, Inc. (OTC:MDCE) traded at $0.00005, down 50.00%.

Key points

  • Medical Care Technologies, Inc. secured a multi-year AI software agreement valued at up to $250,000.
  • The deal marks the company's first external software sale, and initial payment collection has begun.
  • The contract features ongoing financial incentives, though specific software applications remain undisclosed.
  • The company also noted six-figure sales tied to Topps and Fanatics.

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

What is the value of Medical Care Technologies' new AI software contract?

The multi-year agreement is valued at up to $250,000, with initial payment processing already started and additional ongoing incentives included.

Why is this software agreement significant for Medical Care Technologies?

This agreement represents the company's first external commercial sale of its AI software, marking an initial move into revenue generation after focusing on platform development.

Has Medical Care Technologies disclosed what the AI software will be used for?

No, specific application details and scope for the software agreement remain undisclosed.